Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
73.81
+1.14 (1.57%)
Nov 21, 2024, 4:00 PM EST - Market closed
Insmed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 342.96 | 305.21 | 245.36 | 188.46 | 164.41 | 136.47 | Upgrade
|
| Revenue Growth (YoY) | 22.13% | 24.39% | 30.19% | 14.63% | 20.48% | 1287.56% | Upgrade
|
| Cost of Revenue | 78.03 | 65.57 | 55.13 | 44.15 | 39.87 | 24.21 | Upgrade
|
| Gross Profit | 264.92 | 239.64 | 190.23 | 144.31 | 124.54 | 112.26 | Upgrade
|
| Selling, General & Admin | 408.13 | 344.5 | 265.78 | 233.67 | 203.61 | 210.8 | Upgrade
|
| Research & Development | 555.67 | 571.01 | 397.52 | 272.74 | 181.16 | 131.71 | Upgrade
|
| Operating Expenses | 968.85 | 920.56 | 668.36 | 511.47 | 389.77 | 347.5 | Upgrade
|
| Operating Income | -703.93 | -680.93 | -478.12 | -367.16 | -265.23 | -235.25 | Upgrade
|
| Interest Expense | -83.28 | -81.37 | -27.97 | -40.47 | -29.56 | -27.71 | Upgrade
|
| Interest & Investment Income | 45.9 | 42.13 | 11.08 | 0.17 | 1.7 | 9.92 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.64 | 1.86 | -5.94 | -3.33 | 0.41 | -0.53 | Upgrade
|
| EBT Excluding Unusual Items | -738.66 | -718.32 | -500.95 | -410.79 | -292.69 | -253.56 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -0.6 | - | - | Upgrade
|
| Other Unusual Items | -122.18 | -28.7 | 20.8 | -25.02 | - | - | Upgrade
|
| Pretax Income | -860.85 | -747.01 | -480.15 | -436.41 | -292.69 | -253.56 | Upgrade
|
| Income Tax Expense | 3.44 | 2.56 | 1.38 | -1.76 | 1.4 | 0.78 | Upgrade
|
| Net Income | -864.29 | -749.57 | -481.53 | -434.65 | -294.09 | -254.34 | Upgrade
|
| Net Income to Common | -864.29 | -749.57 | -481.53 | -434.65 | -294.09 | -254.34 | Upgrade
|
| Shares Outstanding (Basic) | 155 | 140 | 123 | 112 | 98 | 85 | Upgrade
|
| Shares Outstanding (Diluted) | 155 | 140 | 123 | 112 | 98 | 85 | Upgrade
|
| Shares Change (YoY) | 13.14% | 14.14% | 9.74% | 14.86% | 15.43% | 9.98% | Upgrade
|
| EPS (Basic) | -5.56 | -5.34 | -3.91 | -3.88 | -3.01 | -3.01 | Upgrade
|
| EPS (Diluted) | -5.56 | -5.34 | -3.91 | -3.88 | -3.01 | -3.01 | Upgrade
|
| Free Cash Flow | -636.03 | -549.54 | -410.32 | -370.59 | -225.59 | -292.92 | Upgrade
|
| Free Cash Flow Per Share | -4.09 | -3.91 | -3.33 | -3.31 | -2.31 | -3.46 | Upgrade
|
| Gross Margin | 77.25% | 78.52% | 77.53% | 76.57% | 75.75% | 82.26% | Upgrade
|
| Operating Margin | -205.25% | -223.10% | -194.87% | -194.82% | -161.32% | -172.38% | Upgrade
|
| Profit Margin | -252.01% | -245.59% | -196.26% | -230.63% | -178.87% | -186.37% | Upgrade
|
| Free Cash Flow Margin | -185.45% | -180.05% | -167.23% | -196.64% | -137.21% | -214.64% | Upgrade
|
| EBITDA | -695.06 | -672.49 | -470.68 | -351.9 | -250 | -224.7 | Upgrade
|
| EBITDA Margin | -202.67% | -220.34% | -191.84% | -186.72% | -152.06% | -164.66% | Upgrade
|
| D&A For EBITDA | 8.87 | 8.44 | 7.44 | 15.26 | 15.23 | 10.54 | Upgrade
|
| EBIT | -703.93 | -680.93 | -478.12 | -367.16 | -265.23 | -235.25 | Upgrade
|
| EBIT Margin | -205.25% | -223.10% | -194.87% | -194.82% | -161.32% | -172.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.